Response to cardiovascular effects of nonproteolytic activation of prorenin [6]

Hypertension

Volumn 48, Issue 6, 2006, Pages

  Ichihara, Atsuhiro ^a   Kaneshiro, Yuki ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN ANTAGONIST; COLLAGEN; PEPTIDE DERIVATIVE; PRORENIN; PROTEIN KINASE; RENIN INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; CARDIOVASCULAR EFFECT; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DIABETES MELLITUS; HEART LEFT VENTRICLE MASS; HEART MUSCLE FIBROSIS; HYPERTENSION; LETTER; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SPONTANEOUSLY HYPERTENSIVE RAT; STROKE; VASCULAR SMOOTH MUSCLE;

EID: 33751081792     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000247257.33104.1d     Document Type: Letter

References (5)

1. Danser AH. Prorenin: back into the arena. Hypertension. 2006;47:824-826.
2. Ichihara A, Kaneshiro Y, Takemitsu T, Sakoda M, Suzuki F, Nakagawa T, Nishiyama A, Inagami T, Hayashi M. Non-proteolytic activation of prorenin contributes to development of cardiac fibrosis in genetic hypertension. Hypertension. 2006;47:894-900.
3. Ichihara A, Hayashi M, Kaneshiro Y, Suzuki F, Nakagawa T, Tada Y, Koura Y, Nishiyama A, Okada H, Uddin MN, Nabi AHMN, Ishida Y, Inagami T, Saruta T. Inhibition of diabetic nephropathy by a decoy peptide corresponding to the "handle" region for non-proteolytic activation of prorenin. J Clin Invest. 2004;114:1128-1135.
4. Nguyen G, Delarue F, Burckle C, Bouzhir L, Giller T, Sraer J-D. Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest. 2002;109:1417-1427.
5. Susic D, Lippton H, Knight M, Frohlich ED. Cardiovascular effects of nonproteolytic activation of prorenin. Hypertension. 2006;48:e113.